EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Open Access · CC BY-NC-ND 4.0

Pioneering a Hybrid Decentralized Clinical Trial in South Korea: Assessing Feasibility, Data Integrity, and Participant Perceptions

Eunwoo Kim iD, Sungyeun Bae iD, Ki Young Huh iD, SeungHwan Lee iD, Wonsuk Shin iD, Hyounggyoon Yoo, Namyi Gu iD, Anhye Kim iD

Clinical and Translational Science · 2026-06 · 19 (6)

DOI: 10.1111/cts.70618 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Translational Science, online erschienen am 07.06.2026. Verfasst von Eunwoo Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, CHA University Bundang Medical Center, Seongnam, Republic of Korea. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Ministry of Health and Welfare of the Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials with decentralized elements (DCTs) may improve accessibility and convenience by reducing the need for frequent on‐site visits; however, empirical evidence remains limited. Within a Phase 1 pharmacokinetic drug–drug interaction (DDI) study, we concurrently implemented an additional study arm incorporating decentralized elements to evaluate feasibility, data integrity, and participant perceptions compared to conventional on‐site procedures. In this open‐label, hybrid DCT, 20 healthy adults were randomized in a 1:1 ratio to either the DCT arm or the conventional arm. Between on‐site periods (Periods 1 and 3), 5‐day paroxetine dosing was administered during arm‐differentiated Period 2. During this period, DCT arm participants self‐administered paroxetine with a wearable dosing‐monitoring and remote adverse events (AEs) reporting, whereas conventional‐arm participants underwent on‐site dosing and AE reporting. Participant burden was assessed using a survey conducted at completion of the study. In Period 2, the DCT arm achieved 100% dosing adherence, whereas one participant in the conventional arm missed the on‐site dose. Wearable device records showed 2% missing data with high concordance with paper logs (mean difference, 0.24 min). AE incidence was comparable between the arms, suggesting that remote reporting maintained AE detection sensitivity. Participants rated app/web‐based methods as the least burdensome, followed by paper, wearable devices, and on‐site visits. Burden scores for electronic versus paper AE reporting showed no significant differences between or within arms. This study, one of the earliest reported DCTs in the Republic of Korea, demonstrated the feasibility and reliability of decentralized self‐administration with wearable monitoring and remote AE reporting. These findings support the potential of hybrid DCTs in offering efficient and participant‐friendly alternatives to conventional approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HumansFemaleFeasibility StudiesAdultMaleRepublic of KoreaWearable Electronic DevicesYoung AdultMiddle AgedRemote Patient MonitoringDrug Interactions

Stichwörter der Autor:innen

decentralized clinical trialsfeasibility studieshybrid trial designmobile applicationspatient‐centered caresurveys and questionnaireswearable electronic devices

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, CHA University Bundang Medical Center, Seongnam, Republic of Korea.
  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Physiology, CHA University School of Medicine, Pocheon, Republic of Korea.
  • Department of Pharmacology, CHA University School of Medicine, Pocheon, Republic of Korea.
  • Department of Clinical Pharmacology and Therapeutics, Dongguk University College of Medicine and Dongguk University Ilsan Hospital, Goyang, Republic of Korea.

ORCID-Profile: Eunwoo Kim, Sungyeun Bae, Ki Young Huh, SeungHwan Lee, Wonsuk Shin, Namyi Gu, Anhye Kim

Förderung

  • the Ministry of Health and Welfare of the Republic of Korea

Zitieren

APA

Kim, E., Bae, S., Huh, K. Y., Lee, S., Shin, W., Yoo, H., Gu, N., & Kim, A. (2026). Pioneering a Hybrid Decentralized Clinical Trial in South Korea: Assessing Feasibility, Data Integrity, and Participant Perceptions. Clinical and Translational Science, 19(6). https://doi.org/10.1111/cts.70618

Vancouver

Kim E, Bae S, Huh KY, Lee S, Shin W, Yoo H, et al. Pioneering a Hybrid Decentralized Clinical Trial in South Korea: Assessing Feasibility, Data Integrity, and Participant Perceptions. Clinical and Translational Science. 2026;19(6). doi:10.1111/cts.70618

BibTeX
@article{Kim2026,
  author = {Kim, Eunwoo and Bae, Sungyeun and Huh, Ki Young and Lee, SeungHwan and Shin, Wonsuk and Yoo, Hyounggyoon and Gu, Namyi and Kim, Anhye},
  title = {Pioneering a Hybrid Decentralized Clinical Trial in South Korea: Assessing Feasibility, Data Integrity, and Participant Perceptions},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1111/cts.70618}
}
Kostenlos starten →